Hemostasis Today

September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Faheema Hasan: New ASH 2026 Guidelines Redefine Initial and Second-Line ITP Therapy
Sep 9, 2026, 05:52

Faheema Hasan: New ASH 2026 Guidelines Redefine Initial and Second-Line ITP Therapy

Faheema Hasan, Associate Professor at United Medicity, shared a post on LinkedIn about a recent article by Adam Cuker et al, published in Blood Advances, adding:

ASH 2026 ITP update is finally here — after 7 long years and for all of us managing adult ITPs, it is exciting.

It’s exciting to see how closely it reflects what many of us have already been doing in practice over the last 4–5 years.

Like in other hematologic diseases, our treatment targets are evolving:

From simply achieving a ‘safe platelet count’, we are moving towards

  • patient-centred outcomes
  • better quality of life
  • sustained remission, treatment-free remission and even cure

Take home:

  • 2019 = Steroids first
  • 2026 = Steroid-sparing, earlier.”

Title: American Society of Hematology 2026 Guidelines for Immune Thrombocytopenia (ITP): Initial and Second-Line Therapy in Adults with Primary ITP

Authors: Adam Cuker, Deirdra R Terrell, Honieh Sowdagar, Donald M Arnold, Sylvain Audia, James B. Bussel, Tomas Jose Gonzalez-Lopez, Rachael F. Grace, Camila Masias, Keith R. McCrae, Mirjana Mitrovic, Cindy E. Neunert, Sandhya Ramanathan Panch, Surbhi Shah, Brenda G Shy, Jessica VandeVelde, Douglas B. Cines, Sara K Vesely

Faheema Hasan: New ASH 2026 Guidelines Redefine Initial and Second-Line ITP Therapy

Stay updated on all scientific advances with Hemostasis Today.